APA

Gaster L. M., Ham P., Joiner G. F., King F. D., Mulholland K. R., Wyman P. A., Hagan J. J., Price G. W., Roberts C., Routledge C., Selkirk J., Slade P. D. & Middlemiss D. N. (19990225). The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. : Annals of the New York Academy of Sciences.

Chicago

Gaster L M, Ham P, Joiner G F, King F D, Mulholland K R, Wyman P A, Hagan J J, Price G W, Roberts C, Routledge C, Selkirk J, Slade P D and Middlemiss D N. 19990225. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. : Annals of the New York Academy of Sciences.

Harvard

Gaster L. M., Ham P., Joiner G. F., King F. D., Mulholland K. R., Wyman P. A., Hagan J. J., Price G. W., Roberts C., Routledge C., Selkirk J., Slade P. D. and Middlemiss D. N. (19990225). The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. : Annals of the New York Academy of Sciences.

MLA

Gaster L M, Ham P, Joiner G F, King F D, Mulholland K R, Wyman P A, Hagan J J, Price G W, Roberts C, Routledge C, Selkirk J, Slade P D and Middlemiss D N. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. : Annals of the New York Academy of Sciences. 19990225.